stack of letters mail envelopes
Marketing

BMS, Novartis, Gilead, Iovance dinged in CBER untitled letters

Promotional materials for a handful of biologics have found their way into the FDA’s hot seat.
Andrea Park Mar 30, 2026 10:00pm
Food and Drug Administration

Regulatory tracker: GSK's Exdensur wins asthma nod in China

Mar 30, 2026 2:00pm
HCPengagementis stuck in the past hereshowpre-consultprecision unlockswhatsnext

Smarter HCP engagement starts earlier

Brought to you by Phreesia Network Solutions
Man with insomnia in bed

Idorsia eyes pediatric insomnia market with ph. 2 win

Mar 30, 2026 11:25am
Takeda

Takeda to cut 634 US jobs in massive $1.3B restructuring

Mar 30, 2026 10:29am
Strike signs

Samsung Biologics faces threat of strike action in Korea

Mar 30, 2026 10:08am
More News

Biogen looks to shake up SMA status quo with Spinraza HD nod

Mar 30, 2026 9:58am

Fierce Madness Drug Name Tournament 2026—Elite 8 voting open

Mar 27, 2026 3:00pm

Bayer signs Ludacris to One A Day multivitamin campaign

Mar 27, 2026 10:47am

Rocket is priming a limited launch of its 1st gene therapy nod

Mar 27, 2026 10:25am